SYNTHESIS AND BIOLOGICAL-ACTIVITIES OF NEW 2-SUBSTITUTED 1,4-BENZOXAZINE DERIVATIVES

被引:0
作者
KAJINO, M [1 ]
SHIBOUTA, Y [1 ]
NISHIKAWA, K [1 ]
MEGURO, K [1 ]
机构
[1] TAKEDA CHEM IND LTD, DIV RES & DEV, BIOL RES LABS, OSAKA 532, JAPAN
关键词
1,4-BENZOXAZINE; PIPERAZINE; CALMODULIN ANTAGONIST; ANTIHYPERTENSIVE ACTIVITY; INTRACELLULAR CALCIUM ANTAGONIST; SPONTANEOUSLY HYPERTENSIVE RAT;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of new 1,4-benzoxazine derivatives (XI, XII) possessing (4-phenyl-1-piperazinyl)alkyl moieties at the 2-position and related compounds (XIII) were synthesized and tested for calcium antagonistic, calmodulin antagonistic and antihypertensive activities. Various compounds had in vitro calmodulin antagonistic activity superior or comparable to that of trifluoperazine. Among these compounds, tetrahydronaphtho[2,3-b][1,4]oxazine derivatives such as 51, 53, 54, 58, 59, 60, 73 and 75 showed potent antihypertensive effects in spontaneously hypertensive rats. Optical isomers of 51 were also synthesized and evaluated biologically. No differences in biological activities were seen between the enantiomers.
引用
收藏
页码:2896 / 2905
页数:10
相关论文
共 50 条
  • [41] New N'-Arylidene-2-[(4-Nitrophenyl) Piperazin-1-yl]Acetohydrazide Derivatives: Synthesis and Anticancer Activity Investigation
    Yurttas, Leyla
    Kaplancikli, Zafer A.
    Gorgulu-Kahyaoglu, Sennur
    LETTERS IN DRUG DESIGN & DISCOVERY, 2017, 14 (08) : 910 - 917
  • [42] Synthesis and screening of 2-(2-(4-substituted piperazine-1-yl)-5-phenylthiazol-4-yl)-3-aryl quinazolinone derivatives as anticancer agents
    Sharma, Ritesh N.
    Ravani, Rasik
    MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (06) : 2788 - 2794
  • [43] Synthesis and screening of 2-(2-(4-substituted piperazine-1-yl)-5-phenylthiazol-4-yl)-3-aryl quinazolinone derivatives as anticancer agents
    Ritesh N. Sharma
    Rasik Ravani
    Medicinal Chemistry Research, 2013, 22 : 2788 - 2794
  • [44] Synthesis and Biological Activities of Novel 5-(Pyridine-3-y1)-1,2,4-triazole Mannich Bases and Bis-Mannich Bases Containing Piperazine Moiety
    Zhang Yan
    Wang Baolei
    Zhan Yizhou
    Zhang Liyuan
    Li Yonghong
    Li Zhengming
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2016, 37 (06): : 1100 - 1107
  • [45] Synthesis, Characterization, and Biological Evaluation of 2-(N-((2′-(2H-tetrazole-5-yl)-[1,1′-biphenyl]-4yl)-methyl)-pentanamido)-3-methyl Butanoic Acid Derivatives
    Masood, Anum
    Khan, Mohsin Abbas
    Ahmad, Irshad
    Breena
    Raza, Asim
    Ullah, Farhat
    Shah, Syed Adnan Ali
    MOLECULES, 2023, 28 (04):
  • [46] Design, synthesis, and evaluation of the anticancer properties of a novel series of carboxamides, sulfonamides, ureas, and thioureas derived from 1,2,4-oxadiazol-3-ylmethyl-piperazin-1-yl substituted with pyrazolo[1,5-a]pyrimidine derivatives
    Kumar, A. K. Ajeesh
    Nair, Kanya B.
    Bodke, Yadav D.
    Sambasivam, Ganesh
    Bhat, Kishore G.
    MONATSHEFTE FUR CHEMIE, 2016, 147 (12): : 2221 - 2234
  • [47] Design, synthesis, and evaluation of the anticancer properties of a novel series of carboxamides, sulfonamides, ureas, and thioureas derived from 1,2,4-oxadiazol-3-ylmethyl-piperazin-1-yl substituted with pyrazolo[1,5-a]pyrimidine derivatives
    A. K. Ajeesh Kumar
    Kanya B. Nair
    Yadav D. Bodke
    Ganesh Sambasivam
    Kishore G. Bhat
    Monatshefte für Chemie - Chemical Monthly, 2016, 147 : 2221 - 2234
  • [48] Synthesis, biological activities and SAR studies of new 3-substitutedphenyl-4-substitutedbenzylideneamino-1,2,4-triazole Mannich bases and bis-Mannich bases as ketol-acid reductoisomerase inhibitors
    Wang, Bao-Lei
    Zhang, Li-Yuan
    Liu, Xing-Hai
    Ma, Yi
    Zhang, Yan
    Li, Zheng-Ming
    Zhang, Xiao
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (24) : 5457 - 5462
  • [49] Synthesis of 2-(morpholin-4-yl)-5-(piperazin-1-yl)pyrido[4,3-d]pyrimidine derivatives, crsystal structure, molecular docking studies, and anti-oxidant activities
    Mareedu, Rajendra Swami
    Pandeeswaran, M.
    JOURNAL OF MOLECULAR STRUCTURE, 2025, 1322